跳至主要内容
临床试验/DRKS00026103
DRKS00026103尚未招募未知

Rapid assessment of small bowel bleeding by HemoPill® in transit - Rabbit

Vivantes Klinikum im Friedrichshain Berlin Gastroenterologie0 个研究点目标入组 100 人开始时间: 2021年11月10日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Suspicion of small intestine bleeding with melena and exclusion of a bleeding source in an esophagogastroduodenoscopy
  • 2. Written declaration of consent for participation in the study after detailed oral and written information is available
  • 3. Age = 18 years.
  • 4. The ability to give consent is given.
  • 5. Compliance is expected to be given.
  • 6. Exclusion of pregnancy.

排除标准

  • 1. Lack of patient consent
  • 2. Moribund patient
  • 3. Pregnancy or lactation
  • 4. Participants whose ability to consent is limited (e.g. psychiatric illnesses, language problems, no adequate education possible)
  • 5. Age < 18 years
  • 6. Contraindications to carrying out an examination with HemoPill® acute
  • 7. Non-Compliance
  • 8. Patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis)
  • 9. Surgically altered anatomy of the upper GI tract (e.g. gastric resection)
  • 10. Known or suspected gastrointestinal obstructions, strictures, fistulas or known diverticula
  • 11. Patients with pacemakers, defibrillators or other implantable electromedical devices
  • 12. Known allergy to parylene (capsule surface)
  • 13. Need for a timely MRI scan

研究者

发起方
Vivantes Klinikum im Friedrichshain Berlin Gastroenterologie

相似试验

Rapid assessment of small bowel bleeding by... | 临床试验